2023/0491 - PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML SOL INJ FRS]
TED · 556630-2026Award noticeawardedNo deadline given
Value
Estimated€1,364,407 · 1,364,406.69 EUR
Awarded—
WinnerROCHE Farmacêutica Química, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 24 | — | 2026-08-11 |
| GILEAD SCIENCES, LDA | 23 | — | 2026-08-11 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 17 | €1,569,649 | 2026-08-11 |
| NOVARTIS FARMA - PROD.FARM SA | 12 | — | 2026-08-11 |
| TAKEDA-Farmaceuticos Portugal, Lda | 11 | €554,760 | 2026-08-11 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML SOL INJ FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-09 | 2023/0491 -PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-07-21 | 2023/0491 - TRASTUZUMAB [600 MG/ 5 ML SOL INJ SC FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-07-07 | 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-05-12 | 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-02 | 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-07-28 | 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |